DrugPatentWatch Database Preview
Profile for Australia Patent: 2003207016
US Patent Family Members and Approved Drugs for Australia Patent: 2003207016
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Aug 3, 2021 | Glaxo Grp Ltd | BREO ELLIPTA | fluticasone furoate; vilanterol trifenatate |
➤ Sign Up | Aug 3, 2021 | Glaxosmithkline | TRELEGY ELLIPTA | fluticasone furoate; umeclidinium bromide; vilanterol trifenatate |
➤ Sign Up | Aug 3, 2021 | Glaxosmithkline Cons | FLONASE SENSIMIST ALLERGY RELIEF | fluticasone furoate |
➤ Sign Up | Aug 3, 2021 | Glaxo Grp Ltd | BREO ELLIPTA | fluticasone furoate; vilanterol trifenatate |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |